Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 19, 2007
Patent Application Number
10609671
Date Filed
July 1, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to improved antibodies against tumor surface antigens and their use in the treatment of tumors. Of particular interest are highly stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA), especially the antibody we have termed sm3E, which is derived from the scFv antibody MFE-23. Such antibodies have the potential for improved therapeutic efficacy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
